Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel phthalide preparation method avoiding high-pressure hydrogenation. Ideal for agrochemical intermediates like kresoxim-methyl with reduced costs.
Patent CN113549102B reveals a thiourea-free ozone/CO method for removing p-methoxyphenyl groups, offering high purity and reduced sulfur waste for API manufacturing.
Novel glycine-based synthetic route for Tigecycline API ensures high purity and reduced impurities for reliable pharmaceutical supply chains and cost efficiency.
Patent CN103773724B reveals biocatalytic route for high-purity chiral alcohol. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN105348250A reveals novel lipid-lowering compound synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN115093313A discloses high-enantioselectivity rhodium catalysts for C-H activation, offering scalable routes for pharmaceutical intermediates.
Patent CN102876759A details a chemo-enzymatic NAD preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107056756B reveals a method achieving 98.4% purity using cyclic amine catalysts, offering significant cost reduction and scalability for API manufacturing.
Patent CN101573330A reveals a novel stereo-selective route for trans-[18F]-FACBC precursors, offering significant cost reduction in PET tracer manufacturing and supply chain reliability.
Patent CN101993468A details a high-yield synthesis of dienogest intermediates. Discover cost-effective manufacturing strategies and supply chain advantages for hormonal APIs.
Patent CN118638091A details a novel synthesis for oxabenzo[3.2.2] skeletons, offering cost reduction and scalable manufacturing for high-purity pharmaceutical intermediates.
Advanced rhodium-catalyzed synthesis of gem-difluorocyclopentane intermediates offers high yield and scalability for pharmaceutical manufacturing supply chains.
Patent CN105198863B reveals a novel crystallization method for Losartan, achieving 99.5% purity without salt conversion, offering significant cost reduction in API manufacturing.
Patent CN101090770B discloses a dual-ligand Rh-catalyzed system for asymmetric hydrogenation, delivering superior enantioselectivity and cost efficiency for API manufacturing.
Patent CN117164599A reveals a continuous three-step method for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for ADC drug production.
Patent CN107983349B reveals a visible light catalyst for 1,3-butadiyne synthesis offering green manufacturing and supply chain efficiency for pharmaceutical intermediates.
Patent CN114032258B reveals enzymatic route for L-butylphthalide intermediate. Offers high purity and cost efficiency for pharmaceutical supply chains.
Patent CN109438264A reveals high-yield Rh-catalyzed synthesis for indene amines. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN109438264A reveals Rhodium-catalyzed route for high-purity indenes amine. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced process for CNS drug intermediates via optimized Pd-coupling. Enhances yield and scalability for cost reduction in API manufacturing.